menu
    • menu

    Company profile for Qilu Pharmaceutical

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Located in Jinan, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing, manufacturing and marketing of generic drugs and active pharmaceutical ingredients in the therapeutic areas of Oncology, Cerebrovascular & Cardiovascular, Infections, Psychological and Neurological System, Respiratory System, Ophthalmological Diseases, etc. Always committing itself to meet the needs of the ...
    Located in Jinan, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing, manufacturing and marketing of generic drugs and active pharmaceutical ingredients in the therapeutic areas of Oncology, Cerebrovascular & Cardiovascular, Infections, Psychological and Neurological System, Respiratory System, Ophthalmological Diseases, etc. Always committing itself to meet the needs of the patients and the society. Qilu pharmaceutical provides high-quality products by adopting advanced technology. Qilu has 8000 employees , 5,000 of them have junior college or above educational backgrounp.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Qilu PharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    No.8888, Youyou Road, High-tech Zone, Jinan City, Shandong Province
    Telephone
    Telephone
    +86 0531-83126666
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.qilu-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI India

    Not Confirmed

    envelop Contact Supplier

    CPhI India

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    mic“Over 500 million syringes of our hyaluronic acid have been safely used worldwide”

    This week, SpeakPharma interviews Marie-Armelle Floc’h, Chief of Quality and Regulatory Affairs at HTL Biotechnology, a global leader in the development and the manufacturing of pharmaceutical-grade biopolymers headquartered in Javené, Brittany (France). Since 1992, HTL has pioneered the production of hyaluronic acid (HA) through proprietary biofermentation, achieving unmatched purity and consistency for applications in ophthalmology, dermatology and rheumatology. Floc’h highlights how HTL Biotechnology’s compelling portfolio of pharmaceutical-grade biopolymers is built on uncompromising quality standards. These standards have enabled the company to supply biopolymers for over 30 years without a single batch recall, firmly establishing its reputation for reliability and excellence. She also discusses the inauguration of HTL Biotechnology’s new sterile hyaluronic acid production unit — a major milestone that reinforces the company’s leadership in biopolymer manufacturing and enables the development of innovative formulations combining hyaluronic acid with thermo-sensitive active ingredients. This new capability opens the door to advanced biomedical applications where safety, stability and efficacy must be preserved without compromising the integrity of delicate molecules and which requires the highest quality standards. What distinguishes HTL Biotechnology’s biopolymer platforms in the market today? HTL Biotechnology has built its reputation on delivering pharmaceutical‑grade biopolymers (hyaluronic acid, polynucleotides and recombinant collagen) with unmatched purity and consistency. Since its founding in 1992, the company has focused on premium quality positioning. With more than 30 years of experience, HTL Biotechnology guarantees pharmaceutical-grade biopolymers of exceptional purity and exemplary consistency to our clients. We have had no batch recalls in 30 years, a record that underlines the rigor and reliability embedded in our processes. This was made possible by our fully-integrated site in France, where R&D laboratories, GMP manufacturing, quality control, and regulatory expertise are brought together under one roof. Such integration allows us to support our clients seamlessly throughout their product development journey, from early innovation through to global commercialization.Also, the inauguration of our new sterile hyaluronic acid production unit expands the possibilities for our HA to be used in advanced formulations with thermo-sensitive active ingredients, while upholding the uncompromising quality that defines HTL Biotechnology.Our operations are guided by internationally recognized standards, including ISO 13485 certification, which ensures the quality and safety required by medical device manufacturers worldwide.In addition, our Halal certification provides our customers with a significant advantage in accessing and expanding into markets where these requirements are essential for commercialization.Beyond certifications, our commitment to supporting global growth is reflected in the Drug Master Files we maintain across five continents, enabling our clients to accelerate product registration and bring innovative therapies to markets across the world more efficiently. By combining craftsmanship with pharmaceutical rigor, supported by state-of-the-art equipment and advanced bio-production methods, we ensure that every batch produced not only meets the strictest standards, but also delivers the reliability and consistency needed across the entire healthcare ecosystem. HIGHLIGHTS// Biopolymers with unmatched purity/record of no batch recalls/integrated facility in France/operations guided by global standards/new sterile HA unit for advanced formulations  Navigating the complex and evolving regulatory frameworks across global markets can be challenging for healthcare companies. Can you tell us more about how HTL Biotechnology supports its partners in this area? Regulatory support is part of our core premium services offer. We provide pharmaceutical regulatory support to ensure products meet the necessary compliance standards, so our partners can focus on their growth. Our dedicated regulatory professionals bring global and regional expertise, with a team specifically supporting customers in Asia. We offer personalized assistance adapted to their products and to the compliance standards of the target market. This includes personalized case-management support for regulatory file submissions with the concerned health authorities to minimize risks of refusal or delay, with the aim of achieving approval quickly and smoothly.Our offer for regulatory support continues beyond approval. We continuously monitor updates to regulations and provide post-commercialization support to our partners to help them manage any necessary regulatory updates.HIGHLIGHTS// Regulatory support offered as premium service/global and regional expertise/personalized case management for faster approvals/continuous regulatory support  How does HTL Biotechnology integrate sustainability and corporate responsibility into its operations? Sustainability is embedded in HTL Biotechnology’s strategic vision and day-to-day operations. In 2024, the company renewed its commitment to environmental responsibility by reinforcing its corporate social responsibility (CSR) roadmap. Tangible progress was made across multiple fronts: a 27 percent reduction in greenhouse gas emissions per kilogram of HA produced between 2021 and 2024, and a 34 percent reduction in water consumption per kilogram of HA since 2020. In 2024, we renewed the ISO 14001:2015 certification for its environmental management system, reflecting rigorous audit protocols and continual improvement cycles. All employees have been trained in the ISO 14001-certified environmental management system, and 78 percent of critical suppliers have signed HTL Biotechnology’s Responsible Purchasing Charter.These results reflect HTL Biotechnology’s structured and proactive approach to reducing its environmental footprint while maintaining the highest standards of quality and compliance.HIGHLIGHTS// Sustainability embedded in strategic vision/strong CSR roadmap with measurable progress/reduction in greenhouse gas emissions/responsible sourcing 

    Impressions: 59

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/over-500-million-syringes-of-our-hyaluronic-acid-have-been-safely-used-worldwide

    PharmaCompass
    04 Nov 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaPartner in End-to-End API ManufacturingPartner in End-to-End API Manufacturing

    Partner in End-to-End API Manufacturing
    Partner in End-to-End API Manufacturing

    reelPartner in End-to-End API Manufacturing

    This PharmaReel showcases Coral Drugs, a global partner in end-to-end API manufacturing with more than 27 years of expertise. Supported by vertically integrated cGMP and ISO-compliant facilities, the company is backed by USFDA and EMA certifications, patents, and advanced micronization capabilities.

    Impressions: 3657

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    The contract development and manufacturing organization (CDMO) sector has emerged as a key partner in new drug development. This was evident from the strategic investments, partnerships, and expansions witnessed in the third quarter (Q3) of 2025. Several CDMOs, such as Cohance Lifesciences, Fermion Oy, Axplora, AGC Pharma Chemicals invested in new projects. Others, including Veranova, Aenova, and Biosynth, expanded capacities, while Ofichem strengthened its footprint with the acquisition of Avivia BV. CDMOs like Fareva, Evonik, and Samsung Biologics forged strategic partnerships for growth. During Q3, the sector continued to adopt artificial intelligence (AI). This prompted the US Food and Drug Administration (FDA) to issue guidance that recognizes the increasing use of AI and data analytics in drug development.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available) Cohance, Veranova invest in bioconjugation suites in US; ChemExpress inks ADC deal Earlier this year, Indian drugmaker Suven Pharmaceuticals Limited merged with  leading CDMO Cohance Lifesciences Limited. The merged entity — Cohance Lifesciences — has invested US$ 10 million in a current Good Manufacturing Practice (cGMP) bioconjugation suite at its subsidiary NJ Bio in Princeton, New Jersey.  NJ Bio is executing a major program for an existing innovator client with multiple antibody-drug conjugate (ADC) candidates. Cohance also announced an INR 230 million (approximately US$ 2.58 million) investment in a cGMP oligonucleotide facility at its Hyderabad (India) site. Veranova’s Devens (Massachusetts) site successfully passed a routine FDA cGMP surveillance inspection with a “No Action Indicated” (NAI) classification. Earlier, the company had initiated a US$ 50 million investment to expand its ADC and bioconjugate capabilities at its Devens site. This includes a 9,000-square-foot facility expansion with a new process development lab, two additional cGMP suites, and state-of-the-art bioconjugation development and manufacturing capabilities. These initiatives strengthen the site’s highly potent API (HPAPI) and ADC development and manufacturing capabilities. Biosynth has expanded its Berlin facility with a new GMP bioconjugation suite. The expansion supports the company’s manufacturing capabilities in conjugate vaccines, conjugate drugs, activated polyethylene glycol (PEGs), and polymer-based drug delivery excipients. ChemExpress, Mabwell Bioscience, and Insilico Medicine have entered into a strategic partnership to jointly develop a large ADC compound library and advance next-generation ADC candidates. The collaboration combines Mabwell’s antibody and ADC technology, Insilico’s AI-powered drug design platform, and ChemExpress’s expertise in linker-payload chemistry. Together, they aim to build a complete, AI-driven ADC development model that accelerates discovery, optimization, and commercialization. This partnership is expected to enhance R&D efficiency and deliver safer, more effective cancer treatments.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available) Fermion, Axplora, Aenova increase API manufacturing capacities; ICE Pharma expands India facility Finnish CDMO Fermion Oy has launched a renovation project at its Hanko (Finland) production site to modernize its API manufacturing capabilities. This expansion is part of Fermion's broader strategy to increase production, enhance flexibility in the manufacturing of both existing and future pharmaceutical products, and enable potential contract manufacturing opportunities. German CDMO Axplora has announced a €6.5 million (approximately US$ 7.5 million) investment to expand its API manufacturing capacity at its Vizag site in India. This expansion aims to strengthen both production capabilities and supply chain resilience. India-based Aarti Pharmalabs has inaugurated the first phase of its greenfield manufacturing facility in Gujarat (India). This expansion aims to bolster Aarti's CDMO and contract manufacturing organization (CMO) services, targeting a revenue goal of INR 10 billion (approximately US$ 112 million). Snapdragon Chemistry, which was acquired by Cambrex in 2023, has expanded its Massachusetts facility to better support peptide drug development and manufacturing. With this upgrade, the company can now handle peptide projects from early development through full-scale manufacturing. Italy-headquartered ICE Pharma has expanded its Raichem facility in India. The new facility will enhance the production of ursodeoxycholic acid (UDCA), an API it derives from chicken bile. This expansion increases the site’s raw UDCA output by 120 metric tons annually. Spain-headquartered AGC Pharma Chemicals inaugurated a new advanced manufacturing plant in Barcelona, with an investment of €110 million (approximately US$ 128.3 million). The plant spans 7,500 square meters and integrates cutting-edge technologies to support the entire drug development lifecycle — from R&D to commercial manufacturing. This represents a 30 percent increase in the company’s production capacity and introduces a segment dedicated to HPAPIs. Germany-headquartered Aenova has launched a new hot melt extrusion platform at its Regensburg (Germany) site. This new equipment enables the production of advanced drug formulations, while handling all testing and quality checks in-house. The move strengthens Aenova’s capabilities in developing and manufacturing complex medications. US-based Cytovance Biologics has introduced in-house formulation development services, enhancing its role as a comprehensive partner for biologic drug developers. These services utilize quality-by-design principles to ensure speed, safety, and precision in current and future client programs.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available)  Ofichem acquires Avivia BV; Evonik, Samsung Biologics form strategic collaborations Europe-based CDMO Ofichem Group announced the acquisition of Avivia BV, a formulation development company in the Netherlands. This acquisition is part of Ofichem’s strategy to become a fully integrated provider of development solutions across both drug substance and drug product, with a focus on complex formulations. Ofichem has also acquired Meribel Pharma Solutions’ site in Uppsala (Sweden) to strengthen its support for biotech innovators and expand its presence in the Nordic region.  Simtra BioPharma Solutions has acquired a 65-acre property near its Bloomington, Indiana (US) facility, adding over 300,000 square feet of potential expansion space. With this site, Simtra now has the flexibility to rapidly expand in the US. German specialty chemicals company Evonik is partnering with German biotech Ethris to develop and commercialize a next-generation lipid nanoparticle (LNP) platform for delivering nucleic acid therapies. Evonik will assist in formulation using Ethris’ SNaP LNP technology. The LNP market alone is projected to grow to US$2.3 billion by 2032. Luxembourg-headquartered Fareva has partnered with Zhaoke Ophthalmology to expand its footprint in China’s pharma market. Zhaoke will act as Fareva’s go-to partner for customers seeking pharmaceutical manufacturing in China. Samsung Biologics has signed a 1.8 trillion won (US$ 1.3 billion) manufacturing agreement with an undisclosed US-based drugmaker. And UK-based eXmoor Pharma has partnered with Anthony Nolan to provide end-to-end services for cell therapy developers.  View CDMO Activity Tracker for Q3 2025 (Free Excel Available)  Our view The global CDMO market, valued at around US$ 255 billion in 2025, is projected to grow to over US$ 465 billion by 2032. Significantly, about 60 percent of new drug approvals in the US and over 65 percent in Europe now involve CDMO support. The developments outlined above underscore the increasing role CDMOs are playing today in bringing about growth and innovation in the pharmaceutical industry.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1722

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

    #PharmaFlow by PHARMACOMPASS
    16 Oct 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Qilu Pharma Files Abbreviated NDA for Exparel
    Qilu Pharma Files Abbreviated NDA for Exparel

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174472/0/en/Pacira-BioSciences-Notified-of-Abbreviated-New-Drug-Application-Filing-from-Qilu-Pharmaceutical-Hainan-Co-Ltd-for-EXPAREL.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Qilu Pharm’s Generics Afatinib Receives Tentative Approval in US
    Qilu Pharm’s Generics Afatinib Receives Tentative Approval in US

    08 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213499

    FDA
    08 Oct 2025
    Share Share
    Qilu`s Generics Cyclosporine Receives Approval in US
    Qilu`s Generics Cyclosporine Receives Approval in US

    15 Sep 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219049

    FDA
    15 Sep 2025
    Share Share
    Sagent, Qilu Team up To Broaden Access to Injectables in U.S
    Sagent, Qilu Team up To Broaden Access to Injectables in U.S

    08 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sagent-and-qilu-announce-strategic-collaboration-to-expand-access-to-critical-injectables-in-us-302499316.html

    PR NEWSWIRE
    08 Jul 2025
    Share Share
    Qilu’s Generics Mirabegron Receives Approval in US
    Qilu’s Generics Mirabegron Receives Approval in US

    30 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217989

    FDA
    30 Jun 2025
    Share Share
    Mabwell License Agreement Albipagrastim to Qilu Pharmaceutical
    Mabwell License Agreement Albipagrastim to Qilu Pharmaceutical

    27 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mabwell-announces-novel-drug-technology-license-agreement-with-qilu-pharmaceutical-for-albipagrastim-alfa-for-injection-302493293.html

    PR NEWSWIRE
    27 Jun 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Qilu Pharmaceutical Co., Ltd and get a quotation

    Qilu Pharmaceutical Co., Ltd is a supplier offers 110 products (APIs, Excipients or Intermediates).

    Find a price of Cisplatin bulk with DMF, CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Docetaxel bulk with DMF, CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Granisetron Hydrochloride bulk with CEP, JDMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Irinotecan Hydrochloride bulk with DMF, CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Olanzapine bulk with DMF, CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Oxaliplatin bulk with DMF, CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Piperacillin Sodium bulk with JDMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Solifenacin Succinate bulk with DMF, CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Carboplatin bulk with CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Docetaxel bulk with CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Terbinafine Hydrochloride bulk with JDMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Aripiprazole bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Bortezomib bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cabazitaxel bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Carboplatin bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Carfilzomib bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cariprazine Hydrochloride bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Decitabine bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Etoposide bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Exemestane bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Granisetron Hydrochloride bulk with JDMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Maribavir bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Nicardipine Hydrochloride bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Paliperidone Palmitate bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Palonosetron bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Pemetrexed Disodium bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Piperacillin + Tazobactam bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ropivacaine Hydrochloride bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tiamulin Fumarate bulk with CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tylosin Tartrate bulk with CEP offered by Qilu Pharmaceutical Co., Ltd

    Find a price of ARIPIPRAZOLE MONOHYDRATE (STERILE) bulk with DMF offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Adefovir Dipivoxil bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Carvedilol bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Clofarabine bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Duloxetine Hydrochloride bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Esomeprazole Magnesium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Exemestane bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Olanzapine bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ondansetron bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Risperidone bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tazobactam Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tropisetron hydrochloride bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Vinorelbine Tartrate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Abiraterone Acetate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Amikacin Sulfate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Aprepitant bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Biapenem bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Capecitabine bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Carbaspirin Calcium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefadroxil bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefalonium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefamandole Nafate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefazolin Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefcapene Pivoxil bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefdinir bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefditoren Pivoxil bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefepime bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefixime bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefminox Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefoperazone Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefotaxime bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefotiam Hydrochloride bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefpirome Sulphate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefpodoxime Proxetil bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefprozil bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefquinome Sulfate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ceftazidime bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefteram Pivoxil bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ceftezole Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ceftiofur bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ceftiofur Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ceftizoxime Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ceftriaxone bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cefuroxime Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cephalexin bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cephapirin Benzathine bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Cephapirin Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Decoquinate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Echinacea bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Ertapenem bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Etoricoxib bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Flunixin Meglumine bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Fosaprepitant bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Gamithromycin bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Gefitinib bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Gemcitabine bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Hydroxyurea bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Imatinib Mesylate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Imidocarb Dipropionate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Meropenem bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Montelukast Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Neomycin Sulfate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Nicarbazin bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Olmesartan Medoxomil bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Sildenafil Citrate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Sorafenib bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Spinosyn D bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Sulbactam Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tadalafil bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tegafur bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tenofovir Alafenamide Fumarate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tenofovir Disoproxil Fumarate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tildipirosin bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tilmicosin Phosphate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tulathromycin bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Tylosin Tartrate bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Valnemulin bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Vildagliptin bulk offered by Qilu Pharmaceutical Co., Ltd

    Find a price of Warfarin Sodium bulk offered by Qilu Pharmaceutical Co., Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search